Novartis' profit drops 69%; 550 job cuts planned

sea-maid submitted, created time 2 months 2 weeks (www.fdanews.com)

Swiss drug giant Novartis said Monday that its third-quarter profit dropped 69%, as expenses to buy a stake in eye-care specialist Alcon, higher taxes and last year's gains from selling its Gerber and medical-nutrition business offset growing sales of its cancer and heart drugs.

2 comments | Blog It | Email It | Keywords: economics finance Alcon Novartis big pharma drugs heart drugs cancer Cancer Drugs